Extending adjuvant aromatase inhibitor (letrozole) therapy to 10 yearsImproves disease-free survival, reduces incidence of contralateral breast cancer, but does not improve overall survival. Cancer patients unaware they are more optimistic than their oncologist Poorer patients less likely to survive cancer, new research indicates Standardized auxiliary labels for oral oncology drugs Focus on most significant cautions for each drug, providing more consistent information to patients. Colonoscopy trial a first University of Calgary new study on testicular cancer 'a paradigm shift' Alberta researchers looking into sleep issues for children with cancer ASA a cancer preventive Ontario cancer group aids development of promising new oncology drugs OICR investing $1.2M in development of five promising early-stage oncology drug research projects. Organ transplant patients up to 3 times more likely to die from cancer: study Results suggest recipients need regular screening to catch malignancies early. First Previous 27 28 29 30 31 Next Last